Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics

Invasive Breast Cancer

(2017) Robert W. Carlson et al.   Journal of the National Comprehensive Cancer Network

Updated UK Recommendations for HER2 assessment in breast cancer

(2014) Emad A Rakha et al.   JOURNAL OF CLINICAL PATHOLOGY

Immunohistochemistry Validation Procedures and Practices: A College of American Pathologists Survey of 727 Laboratories

(2013) Lindsay B. Hardy et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Guidelines and considerations for conducting experiments using tissue microarrays

(2013) Mohammad Ilyas et al.   HISTOPATHOLOGY

An International Ki67 Reproducibility Study

(2013) Mei-Yin C. Polley et al.   JNCI-Journal of the National Cancer Institute

Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians

(2013) Pooja Malhotra et al.   TUMOR BIOLOGY

Immunohistochemistry in the era of personalised medicine

(2012) Clare Margaret McCourt et al.   JOURNAL OF CLINICAL PATHOLOGY

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

(2012) Zsuzsanna Varga et al.   PLoS One

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Antibody validation

(2010) Jennifer Bordeaux et al.   BIOTECHNIQUES

A standardized framework for the validation and verification of clinical molecular genetic tests

(2010) Christopher J Mattocks et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

(2009) R. M. Simon et al.   JNCI-Journal of the National Cancer Institute

Transcriptional control of human p53-regulated genes

(2008) Todd Riley et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY